11/28/22 16:03  | 11/23/22  | PNT | Point Biopharma Global Inc. |  | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | IN | D |  | P | 25 | 6.85 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/19 19:39  | 2/1/19  | RARX | Ra Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | Exec VP, | M.d | 0 | 0.00 | 0 | 10 |  | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/17/15 17:03  | 8/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | M.d | 75 | 7.94 | 20 | 10 | 16 | 69 | D | 422 | 287 | 23 | 8 | -10 | -11 | -7 | -2 | -4 | -7 | -78 | -77 | -93 | -93 | 
8/17/15 17:03  | 8/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S.d | -408 | 42.92 | 20 | -10 | -12 | 69 | D | 422 | 287 | 23 | 8 | -10 | -11 | -7 | -2 | -4 | -7 | -78 | -77 | -93 | -93 | 
7/15/15 18:30  | 7/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | M.d | 25 | 3.37 | 23 | 8 | 12 | 69 | D | 525 | 346 | 25 | 29 | 16 | 4 | 2 | 5 | 3 | 2 | -12 | -85 | -91 | -95 | 
7/15/15 18:30  | 7/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S.d | -367 | 48.92 | 23 | -8 | -10 | 69 | D | 525 | 346 | 25 | 29 | 16 | 4 | 2 | 5 | 3 | 2 | -12 | -85 | -91 | -95 | 
6/16/15 17:11  | 6/12/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S.dm | -725 | 41.45 | 20 | -18 | -20 | 69 | D | 443 | 275 | 34 | 8 | 15 | 0 | 3 | 1 | 2 | 8 | 18 | -77 | -77 | -91 | 
6/16/15 17:11  | 6/15/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | M.d | 15 | 2.03 | 20 | 8 | 12 | 69 | D | 443 | 275 | 34 | 8 | 15 | 0 | 3 | 1 | 2 | 8 | 18 | -77 | -77 | -91 | 
5/18/15 17:00  | 5/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | M.d | 30 | 2.03 | 18 | 15 | 23 | 79 | D | 404 | 365 | 66 | 14 | 12 | 6 | 8 | -2 | -1 | 5 | 4 | 6 | -75 | -93 | 
5/18/15 17:00  | 5/14/15  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S.d | -589 | 39.28 | 18 | -15 | -16 | 79 | D | 404 | 365 | 66 | 14 | 12 | 6 | 8 | -2 | -1 | 5 | 4 | 6 | -75 | -93 | 
6/18/14 16:39  | 6/17/14  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S | -169 | 12.51 | 1 | -14 | -15 | 78 | D |  | 52 | -1 | -3 | 23 | 14 | 18 | 7 | 1 | 7 | -23 | 35 | 136 | 254 | 
3/10/14 16:08  | 3/6/14  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S | -62 | 13.65 | 4 | -5 | -5 | 92 | D |  |  | 29 | 5 | -28 | -12 | -12 | -11 | -1 | -4 | -11 | -17 | 21 | 193 | 
2/13/14 17:20  | 2/12/14  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S | -63 | 13.92 | 3 | -5 | -4 | 97 | D |  |  | 64 | 35 | 3 | -20 | -4 | -4 | -1 | -1 | -15 | -38 | -21 | 157 | 
2/11/14 16:12  | 2/7/14  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | M.d | 139 | 1.58 | 2 | 88 | 701 | 101 | D |  |  | 80 | 43 | 6 | -7 | -10 | 2 | -3 | -2 | -14 | -37 | -16 | 147 | 
2/11/14 16:12  | 2/7/14  | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | MA | O | SVP,CFO | S.d | -141 | 14.22 | 2 | -10 | -9 | 101 | D |  |  | 80 | 43 | 6 | -7 | -10 | 2 | -3 | -2 | -14 | -37 | -16 | 147 |